Loading clinical trials...
Loading clinical trials...
Multicentric, observational and prospective study with two groups of treatment: Refractory ascites and non-refractory ascites. All patients should be prescribed beta-adrenergic blockers as primary or ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
NCT02778425 · Hepatic Cirrhosis, Portal Hypertension
NCT06664307 · Portal Pressure Gradient (PPG) Measurement Guided by Endoscopic Ultrasound (EUS), Hepatic Cirrhosis
NCT04682847 · Liver Neoplasms, Hepatic Cirrhosis, and more
NCT03486912 · Hepatic Cirrhosis, Liver Fibrosis, and more
NCT03420768 · Hepatic Cirrhosis, Liver Fibrosis
Hospital Universitario Gregorio Marañón
Madrid
Hospital Universitario Ramón y Cajal
Madrid
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions